Company / AR per Share
Supernus Pharmaceuticals, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.37
FY2025
5-year range
$2.60 / $3.37
FY2021-FY2025
Trend
+29.8%
vs FY2024
Sector context
#30 of 113
Health Care
What the data says
At $3.37, Supernus Pharmaceuticals, Inc.'s ar per share ranks #30 of 113 in the Health Care sector. AR per Share returned to growth in FY2025 after 2 years of decline, reaching $3.37.
Based on SEC 10-K filings.
3.37 in FY2025 with a 5-year CAGR of +4.7%.
Improved from $2.60 to $3.37 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +4.7%
- 10-Year CAGR
- -
Sector benchmark
#30 of 113 in Health CareTop 27% of 113This company $3.37 Sector average $28.83
▼
-88.3% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 29.8% year-over-year.
- Ranks #30 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.37 | +29.8% |
| FY2024 | $2.60 | -0.0% |
| FY2023 | $2.60 | -16.4% |
| FY2022 | $3.11 | +10.3% |
| FY2021 | $2.82 | +5.0% |
| FY2020 | $2.68 | +60.6% |
| FY2019 | $1.67 | +27.5% |
| FY2018 | $1.31 | -0.2% |
| FY2017 | $1.31 | +54.9% |
| FY2016 | $0.85 | +40.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026